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Abstract: This study aimed to evaluate the clinical and radiographic aspects of xenogenic transplantation of rat bone marrow-derived
mesenchymal stem cells (MSCs) for the repair of radial bone defects of rabbit. Bone marrow derived MSCs collected from Wistar rats
were expanded, differentiated, and labeled in the laboratory. In the fourth passage, the cultures were pelleted in aliquots of 107 cells/50 µL
and transplanted in situ into the lesions. Thirty-six rabbits were used in the in vivo study. In all animals, defects were created by removing
a bone segment of 1.0 cm in length in the right radius. The rabbits were divided into four experimental groups: the control group (CG)
received percutaneously administered 50 µL of phosphate buffer (PBS) in the radial bone defect region 24 h after lesion creation; group 1
(G1) had the radial bone defect filled with absorbable gelatin sponge soaked with 50 µL of PBS during the surgery; group 2 (G2) had the
radial bone defect filled with absorbable gelatin sponge soaked with the MSC pellet; and group 3 (G3) received percutaneously the MSC
pellet in the radial bone defect region 24 h after lesion creation. No clinical and radiographic changes consistent with cellular rejection
were observed. Percutaneous MSC xenotransplantation contributed to the repair of experimental radial bone defects.
Key words: Bone repair, cell therapy, collagen, immune response, stem cell

1. Introduction
Mesenchymal stem cells (MSCs) are defined as a
population of multipotent cells able to differentiate and
produce any cell type needed in a repair process, such as
osteoblasts, chondroblasts, neurons, epithelial cells, and
cardiac cells (1,2).
This cell type has become the focus of numerous studies
worldwide for providing clinically promising perspectives
for cell therapy and also for its immunomodulatory potential
(3,4), although the mechanisms of immunosuppression on
inflammatory response and the mechanisms of transplant
rejection are not fully elucidated (5).
Recent studies have described the use of allogeneic
and autologous MSCs for the repair of various tissues
(4,6). However, there is little research involving
xenotransplantation in animals and most of them only
evaluated the cellular interaction in vitro between MSCs
and T lymphocytes.
Because of the great therapeutic potential of
MSCs, in addition to the persistent doubts about their
immunosuppressive capacity in vivo, further studies
* Correspondence: betania.monteiro@gmail.com

are needed to investigate the real potential of xenogenic
transplantation using these cells for tissue repair in
animals. Therefore, this study evaluated clinical and
radiographic aspects of xenogenic transplantation of rat
bone marrow-derived MSCs for the repair of radial bone
defects created in rabbits.
2. Materials and methods
This study was approved by the Institutional Animal Care
Committee (protocol 97/2010).
2.1 Cellular culture
A total of five male, 4-week old Wistar rats were euthanized
using anesthetic overdose. The animals were immersed
in alcohol 70° to ensure antisepsis for cell collection
and were taken to the laminar flow cabinet. The femurs
were disarticulated and removed aseptically. The distal
epiphyses were cut and the medullary canal was flushed
with Dulbecco’s modified Eagle’s medium (DMEM, Gibco,
Grand Island, NY, USA) with low glucose, containing 10%
fetal bovine serum (FBS) (Gibco), 50.0 mg L–1 gentamicin,
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100,000 U L–1 penicillin G potassium, and 1.5 mg L–1
amphotericin B, using a 10.0 mL syringe and a 25G needle.
The collected material was centrifuged at 694 G (2000
rpm) and 22 °C for 10 min, the supernatant was discarded
and the pellet containing the cells was resuspended in a
15.0 mL of DMEM, plated in 25.0 cm2 cell culture flasks,
and incubated in an oven at 37 °C with 5% CO2. Cultures
were monitored daily using an inverted phase contrast
microscope and the culture medium was replaced every
3 days.
At 80% confluence, the bottles were washed with
phosphate buffered saline (PBS) and detached with a
1.0 mL solution of trypsin (Trypsin/EDTA, Cultilab,
Brazil). After incubation for 5 min in an oven, the trypsin
was inactivated with a DMEM complete medium. The
suspension containing the cells was centrifuged at 694 G
(2000 rpm) and 22 °C for 10 min in 15.0 mL Falcon tubes.
The supernatant was discarded and the pellet resuspended
in 5.0 mL of complete medium. After counting and a
cell viability assay with Trypan blue, new plating was
performed to allow cell expansion.
2.2 Osteogenic differentiation
After the fourth passage, the DMEM medium was
supplemented with 10% FBS, 10–8 mol mL–1 dexamethasone,
5.0 mg mL–1 ascorbic acid 2-phosphate, 10.0 mmol L–1
β-glycerophosphate, and incubated at 37 °C for 4 weeks.
At days 7, 14, 21, and 30, the wells of the culture flasks
were washed in PBS and stained with Alizarin red at room
temperature for 5 min, washed with distilled water, and
observed under an inverted phase contrast microscope for
calcium deposition.
2.3 Immunophenotyping of MSCs
The fourth passage cells were incubation in 96-well plates
at a concentration of 1.0 × 105 cells per well. The samples
were individually incubated with the primary antibodies
(anti- CD45 clone 69 mouse, anti-CD90 clone Ox-7 mouse,
anti-CD73 clone 5 F/B9 mouse, and anti-CD54 clone 1A29
mouse) (BD Bioscience, San Jose, CA, USA) for 30 min at
4 °C. Subsequently, the cells were washed with PBS and
incubated with secondary antibody conjugated to Alexa
488 fluorochrome under the same conditions, according
to the methodology described by Monteiro et al. (6). The
samples were analyzed using a FACScan flow cytometer
and CellQuest software.
2.4 MSC nanolabeling
The culture of the fourth passage was nanolabeled
with Qtracker 655 (Invitrogem, São Paulo, Brazil) at a
concentration of 2.0 µL for 2.0 × 104 cells. The cells were
incubated at 37 °C for 60 min and washed with DMEM
three times.
Aliquots of labeled cells were taken 2 h, 24 h, and 7 days
after nanolabeling for in vivo evaluation by fluorescence
microscopy. After nanolabeling, cells were counted and
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separated in centrifuge tubes at the concentration of 1.0
× 107 cells/50 µL of PBS to be used immediately in the
medical and surgical treatments.
2.5 Experimental animals
Thirty-six male New Zealand White rabbits, about 6
months of age and 3.0 kg in body weight were used. Prior
to surgery the rabbits were put on solid-food fasting for
8 h, and preanesthetized with 0.5 mg kg–1 acepromazine
and 5.0 mg kg–1 IM meperidine under intramuscular (IM)
administration. They had their right forelimb shaved
and trichotomized (hair removal) from the scapula to
the metacarpals. Anesthesia was induced intravenously
(IV) with 6.0 mg kg–1 propofol and the maintenance of
anesthesia was performed with isoflurane in semiclosed
anesthetic circuit.
Previous surgical procedures were carried out using
antibiotic prophylaxis with cephalexin (5.0 mg kg–1, IM)
and analgesia with morphine (2.0 mg kg–1, subcutaneous)
in the preoperative period and every 8 h postsurgery for
3 days.
Craniomedial approach to the radius was performed
and a radial bone defect was surgically created by removing
a bone segment of 1.0 cm length located 3.0 cm of the
radiocarpal ulnar joint, using a circular saw. Both ends of
the osteoperiosteal gap were washed with saline solution
to remove the marrow from the distal and proximal
fragments.
Nine rabbits were randomly assigned to four groups
and the following treatments (Figure 1) were carried out:
The
control
group
(CG)
received
percutaneously administered 50.0 µL of PBS in the radial
bone defect region, 24 h after lesion creation;
- Group 1 (G1) had the bone gap filled with absorbable
gelatin sponge (Hemospon - Cremer - Sao Paulo, Brazil)
soaked with 50.0 µL of PBS;
- Group 2 (G2) had the bone gap filled with absorbable
gelatin sponge soaked with the MSC pellet (1.0 × 107
cells/50.0 µL of PBS);
- Group 3 (G3) received percutaneously the MSC pellet
(1.0 × 107 cells/50.0 µL of PBS) in the bone gap region, 24
h after lesion creation.
At the end of the procedure, the muscle fascia and
skin were sutured in both surgical sites. The animals were
monitored for 50 days.
The evaluation included the animal’s behavior
(normal or apathy), body temperature, wound healing,
conformation and weight bearing on the affected limb
on the ground, and ambulation. Peripheral blood was
collected 1 day before surgery and complete blood count
was performed on days 1, 3, and 7.
Evaluation of radiographs from the medial/lateral and
cranialcaudal (KV and 45 mA/s 0.08) views of the operated
limbs was performed immediately postoperative and at
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Figure 1. A radial bone defect was surgically created resulting in a bone gap of 1.0 cm. The animals were then subjected to different
treatments: A) Control group, which had the gap filled with 50.0 µL of PBS, percutaneously in the bone defect region 24 h after making
the bone defect; B) Group 1, in which the gap was filled with absorbable sponge soaked with 50.0 µL of PBS; C) Group 2, in which the
gap was filled with absorbable sponge containing a cell pellet of 107 cells/50.0 μL in PBS. D) Group 3, in which the defect was filled with
a cell pellet containing 107 cells/50.0 μL in PBS, percutaneously in the bone defect region 24 h after making the bone defect.

7, 21, 30, and 50 days, to assess the degree of bone gap
filling. The bone gap filling was quantified as a percentage,
depending on the radiopacity observed in the gap and
compared with the image of day 0 of surgery, using the
Image-Pro Plus software. Measurements were taken three
times to give the mean values of the areas. To calculate the
area, the total filling was considered as 100% and the value
measured proportionally was calculated for percentage
data by a mathematical formula.
2.6 Statistical analysis
Within each group, the body temperatures and leukocyte
counts were analyzed using descriptive statistics and
averages were compared.

The mean percentage of radial bone repair in each
study period was calculated and subjected to ANOVA
F test followed by Tukey’s test in SAEG v 9.1 software
(Sistema para Análises Estatísticas SAEG v. 9.1 Universidade Federal de Viçosa, Viçosa, MG, Brazil) and
Excel spreadsheet. The null hypothesis rejection level was
established as 5% (P ≤ 0.05).
3. Results
The amount of mononuclear cells obtained was always
higher than the minimum recommended for initiating
culture and cell viability (greater than 92.70%). On the
first day, numerous cells of rounded shape were present
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in the culture medium, not allowing the identification of
the cell type (Figure 2a). Adherent cells with fibroblastoid
morphology appeared 24 h after plating in complete
DMEM medium (Figure 2b). After 3 days, the cultures
reached 80% confluence (Figures 2c and 2d); then the
first passage was performed. Intervals of 3–5 days were
required for the other platings to attain the fourth passage.
Scanning electron microscopy confirmed in detail
the fibroblastoid morphology of cells of all plates and
slides from the early stages of culture (Figures 3a and 3b)
and colony forming units in flasks with low cell density
(Figure 3c). In the subsequent evaluations, confluence and
arrangement of cultured cells were also observed (Figure
3d). Cell viability was always greater than 95.50% in the
assessment of each passage.
Samples of each culture in the fourth passage were
negative for CD45 expression (83.09%) and positive for
CD54 (93.83%), CD73 (70.44%), and CD90 (98.82%),
characterizing the cultured cells as MSCs (Figure 4).
Cultures subjected to osteogenic differentiation showed
points of matrix calcification from the 7th day. Mineralized
nodules containing cells with round morphology, similar
to osteoblasts, were observed from the 14th day. High
cytoplasmic red fluorescence was observed in nanolabeled

cells at all times of evaluation, both in the fresh samples and
in the histologically processed pellet. With the remaining
cells in osteogenic differentiation medium, most stem cells
were differentiating into osteogenic cells and tended to
100% differentiation.
In the first 48 h postoperative, the rabbits avoided
weight bearing on the affected limb, but fed normally.
After 72 h, rabbits of G3 occasionally could bear weight
on the affected limb and ambulation was normalized 96
h after surgery. The rabbits of the other groups started
bearing weight on the affected limb after 96 h and only
after that period they started ambulation.
There was no occurrence of hyperthermia after the
treatment. The average patient’s temperature, regardless
of the experimental group, was 39.65 °C throughout the
experimental period. No animal across the groups showed
a fracture of the ulnar bone, wound dehiscence, or any sign
of infection or clinical signs of rejection of the allogeneic
cells and/or collagen sponge.
Leukocyte counts performed the day before surgery
had a mean of 4.93 × 103 µL–1, with no differences among
the groups. On day 1, the means were 4.97 × 103 µL–1 for
CG, 5.15 × 103 µL–1 for G1, 5.27 × 103 µL–1 for G2, and 5.09
× 103 µL–1 for G3, with no significant differences among the

Figure 2. Photomicrographs captured by an inverted optical microscope: A) cells observed after collecting the bone marrow of mice
exhibiting rounded morphology; B) 24 h after initiation of culture, with the appearance of the first fibroblastoid cells; C) the cell culture
having a confluency greater than 80% and cells with fibroblastoid morphology and adhering to the substrate of the culture flask, 72 h
after initiation of culture; D) featured presenting cells with fibroblastoid morphology of the cultured cell 72 h after initiation of culture.
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Figure 3. Photomicrographs in the scanning electron microscope: A) highlighting of fibroblastoid cells 24 h after initiation of culture;
B) small cell density, with fibroblast cells 24 h after initiation of culture; C) cell growth from a colony forming units observed 48 h after
the beginning of cell culture; D) cell culture having the highest confluence, cells with fibroblastoid morphology and adhering to the
substrate of the culture flask, 72 h after initiation of culture. The rounded cells are cells that are in the process of mitosis, scrapping the
adherence.

groups. In the remaining evaluation periods, the means for
leukocyte counts were not significantly different from day
1, regardless of the experimental group, and the largest
mean was 5.96 × 103 µL–1, still within the normal range for
the species.
Radiographs of the operated limbs in the immediate
postoperative showed a radiolucent region with an average
extension of 1.0 cm2. In G1 and G2, the collagen sponge
had no positive radiodensity, which did not interfere in
other subsequent evaluations, generating a confounding
with the bone growth image. Radiographic evaluations
after day 0 were compared with the first radiographs
performed for each animal, and the average bone fill values
were loaded on tables for statistical analysis.
In all experimental groups, the radiographs showed
increased radiopacity in the site of the created gaps. Mainly
in CG and G3, bone growth occurred initially bridging the
fracture gap from one end to the other, and this radiopacity
was increased proportionally over the observation period.
Rabbits of G1 and G2 sometimes showed radiopacity

started in the middle of the gap, indicating mineral matrix
deposition above the osteoconductive membrane.
At day 7 of radiographic evaluation, the rabbits of GC
had a bone filling lower than 5% of the total area (Figure
5a), the rabbits of G1 had an average bone filling of 7%
(Figure 5b), the rabbits of G2 had an average bone filling
of 9% (Figure 5c), and the rabbits of G3 had 18% bone
filling (Figure 5d). At this time of the evaluation, there
was a significant difference of G3 compared with the other
groups, but no difference was found in bone filling of
rabbits of G2 compared with CG and G1.
After 21 days, rabbits of G3 showed radiopacity of the
radial bone defect region corresponding to a mean bone
filling of 90%, without remodeling of the medullary canal.
G2 rabbits showed 79.8% of bone filling, while rabbits of G1
showed bone filling of 71%. Rabbits of CG showed 46.3% of
bone filling. At this time of the evaluation, there was also a
significant difference of G3 in relation to the other groups.
There was no significant difference between G2 and G1, but
both groups differed from the control group.
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Figure 4. A) Evaluation of the frequency of CD45, CD54, CD73, and CD90 by flow cytometry, on bone marrow derived mesenchymal
stem cells of rats. The fluorescence intensity of each surface marker in undifferentiated MSCs (white graphics) is compared with isotype
controls (red graphics). The X-axis represents the fluorescence scale, the cells being positive when exceeding 101. The Y-axis indicates
the number of cells evaluated during the event. a) A dot plot showing the cell population selected for the study (R1), which represented
89.9% homogeneity. The culture samples showed a negative expression of CD45 at 83.09% (b), and 93.83% positive for CD54 expression
(c), 70.44% of CD73 (d), and 98.82% of CD90 (e). B) The fourth cell culture passage submitted to osteogenic differentiation showing the
presence of an extracellular matrix rich in calcium and rounded nodes, similar to osteoblasts in Alizarin Red staining at day 14.
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Figure 5. Radiographic images obtained at 7 days postsurgery demonstrating bone repair in each treatment: A) animals of the control
group showing less than 5% bone filling of the total area; B) animals of group 1 showing an average bone filling of 7%; C) animals of
group 2 with an average bone repair of 9%; D) animals of group 3 showing an average bone repair of 18% (scale equal to 1.0 cm).

At 30 days, seven rabbits of G2 had 90% of the bone gap
filling and the other two rabbits showed an average filling
of 79%, without the remodeling of the medullary canal. The
average bone filling for G2 was 84.5%. All G3 rabbits, at this
same evaluation time, showed a complete filling of the gap
and an early formation of the medullary canal. G1 rabbits
exhibited 80.7% bone filling, while rabbits of GC exhibited
50% bone filling, which arose from the edges of the gap. At
this evaluation time, again there was a significant difference
among the rabbits of G3 and those from the other groups of
treatments; G2 and G3 did not differ, but were significantly
different from the control group.
After 50 days of evaluation, all rabbits in groups G2
and G3 exhibited complete bone filling of the gap with an
organization of the medullary canal (Figure 6c and 6d).
G1 rabbits showed 97.43% of bone filling (Figure 6b) and
GC showed 71.24% (Figure 6a). There was no significant
difference among the three treatment groups, but they
were significantly different from the control group.
4. Discussion
Adherent cells observed from 24 h of culture cannot be rated
as MSCs, because some hematopoietic cells and fibroblasts
can also be attached. Only by medium replacements and
passages, these cells are removed and the heterogeneity of
the culture gradually decreases, favoring only the growth
of the stem cells of interest (7). After about 15 days, on the
fourth passage, cellular homogeneity occurs and, for this
reason, the characterization steps are performed from that
time.

The expression of surface molecules CD54, CD73, and
CD90 associated with a low expression of CD45 (16.91%)
observed in this study, characterize the analyzed cells
phenotypically as MSCs. The high levels of CD90 and
CD54, both above 90%, are the most reliable findings to
allow this conclusion, since, according to Ocarino et al.
(8) and Kode et al. (9), hematopoietic cells and fibroblasts,
which may be present in the culture, do not express such
markers.
After 5 days in an osteogenic medium, the elongated
fibroblastic cells changed appearance to a more rounded
shape, resembling the morphology of the bone lineage.
Also, the presence of a calcium-rich extracellular matrix,
observed from day 7 and more evident with time,
proved an early differentiation of cultured MSCs into
osteoblasts, confirming the findings of Ocarino et al. (8).
The fluorescent nanocrystals used in this study provided
excellent cell labeling. They could be observed in the fresh
samples obtained directly from the cell suspension after
trypsinization, similar to that observed by Fischer et al.
(10).
The immunoprivileged properties of mesenchymal
stem cells have also been confirmed in this study, since
the rabbits in the groups treated with these cells showed
no clinical and hematological signs of animals with
transplant rejection. These immunosuppressive properties
have already been described in vitro by Nauta and Fibbe
(3), Kode et al. (9), and Zhao et al. (11), and tested in
vivo by Hernigou et al. (12) as autologous transplants,
Monteiro et al. (6) as isogeneic transplants, and Chuang
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Figure 6. Radiographic images obtained at 50 days postsurgery demonstrating bone repair in each treatment: A) animals of the group
control presenting a bone filling equivalent of 71.24% of the total area; B) animals of group 1 showing a filling average of 97.43%; C)
animals of group 2 showing a complete bone repair of defects and early organization of the medullary canal; D) animals of group 3
showing a complete bone repair of defect and organization of the medullary canal (scale equal to 1.0 cm).

et al. (13) in allogeneic transplantation. Regarding
xenogeneic transplantation, with results similar to those
found by our research group, Chuang et al. (14) have
succeeded in performing xenotransplantation of human
stem cells in rats’ calvaria.
In this study, it was also demonstrated that
xenotransplantation of rat bone marrow-derived
mesenchymal stem cells efficiently promoted bone repair
of gaps created in the radius of rabbits, which were not
immunosuppressed over the study period. Radiographic
findings showed that the contribution of the cells in the
bone repair process are similar to those reported by Shoji
et al. (15) when treating femoral fractures in rats with
human adipose-tissue derived mesenchymal stem cells.
In both studies, the favorable effects of stem cells led to a
functional recovery of the operated limb in less time when
compared with the other experimental groups.
The sponge used inside the gap helped with bone healing
by acting as an osteoconductive agent, in comparison
with the control group. As described by Kwan et al. (16),
gelatin or collagen sponges are considered an ideal threedimensional matrix support to provide growth and cell
expansion in vivo, as well as hyaluronic acid and chitosan,
justifying what was observed for radiography. However,
no differences were found between the groups in which
the defect was filled with only the sponge and the group
in which the defect was filled with the sponge soaked with
cell pellet. When culturing cells in growth plates containing
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the sponge, we observed that the cells did not adhere to the
sponge pores. From this finding, it can be inferred that the
sponge pore sizes are larger than that recommended in the
literature to provide optimal cell growth. For this reason,
the treatment with stem cells did not result in advantages in
the process of bone repair. The collagen sponge used in the
treatments has osteoconductive properties, but, because of
its pore size, it was not a suitable platform for growth and
expansion of stem cells used in the treatment of G2.
In this study, using clinical and radiographic
evaluations, we concluded that xenotransplantation
of rat bone marrow-derived mesenchymal stem cells
percutaneously applied 24 h after the creation of a bone
defect contributed positively to the repair of gaps in the
radius of rabbits and did not cause rejection by the host.
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